Vertex Pharmaceuticals Inc (VRTX)
437.10
+8.51
(+1.99%)
USD |
NASDAQ |
May 15, 15:05
Vertex Pharmaceuticals Gross Profit (Quarterly): 2.348B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.348B |
December 31, 2023 | 2.150B |
September 30, 2023 | 2.165B |
June 30, 2023 | 2.185B |
March 31, 2023 | 2.108B |
December 31, 2022 | 2.019B |
September 30, 2022 | 2.045B |
June 30, 2022 | 1.934B |
March 31, 2022 | 1.852B |
December 31, 2021 | 1.825B |
September 30, 2021 | 1.748B |
June 30, 2021 | 1.565B |
March 31, 2021 | 1.532B |
December 31, 2020 | 1.425B |
September 30, 2020 | 1.352B |
June 30, 2020 | 1.340B |
March 31, 2020 | 1.353B |
December 31, 2019 | 1.228B |
September 30, 2019 | 817.91M |
June 30, 2019 | 805.55M |
March 31, 2019 | 763.34M |
December 31, 2018 | 747.82M |
September 30, 2018 | 673.28M |
June 30, 2018 | 647.78M |
March 31, 2018 | 569.19M |
Date | Value |
---|---|
December 31, 2017 | 567.58M |
September 30, 2017 | 505.29M |
June 30, 2017 | 472.93M |
March 31, 2017 | 667.73M |
December 31, 2016 | 398.22M |
September 30, 2016 | 359.71M |
June 30, 2016 | 386.36M |
March 31, 2016 | 347.43M |
December 31, 2015 | 354.55M |
September 30, 2015 | 277.86M |
June 30, 2015 | 149.22M |
March 31, 2015 | 126.20M |
December 31, 2014 | 130.53M |
September 30, 2014 | 164.80M |
June 30, 2014 | 121.12M |
March 31, 2014 | 102.98M |
December 31, 2013 | 328.89M |
September 30, 2013 | 194.36M |
June 30, 2013 | 272.82M |
March 31, 2013 | 285.62M |
December 31, 2012 | 246.28M |
September 30, 2012 | 297.47M |
June 30, 2012 | 303.88M |
March 31, 2012 | 399.53M |
December 31, 2011 | 533.21M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
805.55M
Minimum
Jun 2019
2.348B
Maximum
Mar 2024
1.690B
Average
1.786B
Median
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 4.247B |
Eli Lilly and Co | 7.094B |
Regeneron Pharmaceuticals Inc | 2.711B |
Alpine Immune Sciences Inc | -- |
Editas Medicine Inc | -- |